Novo Nordisk A/S
看多

NOVO is looking at a strong bullish bottoming out

208
NVO is looking at a strong bullish reversal and is likely to head higher after stochastic shows overbought AND long term stochastic shows clear confirmation of oversold crossover.

Price action shows a clear break out of the downtrend line and with the rounding bottom, the stock is likely to target 101 in near to mid-term.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。